Scarica l'app Stockscreener
56.22
1.00%
-0.57
Dopo l'orario di chiusura:
56.22
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$56.79
Aprire:
$56.88
Volume 24 ore:
1.81M
Relative Volume:
0.81
Capitalizzazione di mercato:
$8.81B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
59.81
EPS:
0.94
Flusso di cassa netto:
$245.03M
1 W Prestazione:
+3.48%
1M Prestazione:
-4.36%
6M Prestazione:
-8.18%
1 anno Prestazione:
-20.85%
Intervallo 1D:
$56.02
$57.37
Intervallo di 1 settimana:
$53.89
$57.60
Portata 52W:
$46.01
$80.95
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
(612) 379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Confronta TECH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
56.22 | 8.83B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-07-09 | Iniziato | TD Cowen | Buy |
| 2025-05-30 | Iniziato | Wells Fargo | Overweight |
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
BIO-TECHNE Corp Directors Execute Share Sales - TradingView
Published on: 2025-08-27 14:37:47 - Newser
Using Python tools to backtest Bio Techne Corporation strategiesGDP Growth & Weekly Top Gainers Trade List - Newser
Risk adjusted return profile for Bio Techne Corporation analyzedWeekly Trading Summary & AI Forecast Swing Trade Picks - Newser
Applying big data sentiment scoring on Bio Techne CorporationTrade Ideas & Weekly High Momentum Picks - Newser
Using economic indicators to assess Bio Techne Corporation potentialJuly 2025 Snapshot & Smart Allocation Stock Tips - Newser
Tools to monitor Bio Techne Corporation recovery probability2025 Price Momentum & Scalable Portfolio Growth Methods - Newser
Leading Biotech Company Bio-Techne Set for Three Major Wall Street Healthcare Conference Presentations - Stock Titan
Applying sector rotation models to Bio Techne Corporation2025 Price Momentum & Weekly High Potential Alerts - Newser
What machine learning models say about Bio Techne CorporationBuy Signal & Reliable Price Breakout Signals - Newser
Is Bio Techne Corporation a candidate for recovery playWeekly Trade Summary & Low Drawdown Investment Strategies - Newser
Using Ichimoku Cloud for Bio Techne Corporation technicalsQuarterly Trade Review & Stock Market Timing Techniques - Newser
Advanced analytics toolkit walkthrough for Bio Techne CorporationWeekly Loss Report & Precise Swing Trade Entry Alerts - Newser
Is it time to cut losses on Bio Techne CorporationJuly 2025 Macro Moves & Reliable Price Breakout Signals - Newser
Hong Kong biopharma stocks pull back; Ocumension Bio falls over 15% - AInvest
Bio-Techne Faces NIH & Tariff Uncertainty–Can They Outpace Policy Risks? - Smartkarma
Intraday pattern recognizer results for Bio Techne Corporation2025 Growth vs Value & Weekly Market Pulse Updates - Newser
What momentum shifts mean for Bio Techne CorporationNew Guidance & Community Trade Idea Sharing - Newser
Using flow based indicators on Bio Techne CorporationJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - Newser
Published on: 2025-08-22 19:42:51 - 더경남뉴스
Bio-Techne Upgrade Amid Sector Challenges: Strong Q2 Performance and Easing Tariffs in China - AInvest
Bio-Techne, 10x Genomics, Lumen, EPAM, and ASGN Shares Are Soaring, What You Need To Know - Yahoo Finance
BIO-TECHNE Corp SEC 10-K Report - TradingView
Citi Upgrades Bio-Techne to Buy from Neutral with $70 Price Target - AInvest
Citigroup upgrades Bio-Techne to Buy with a new PT of $70. - AInvest
Understanding Bio Techne Corporation’s price movementQuarterly Profit Summary & Safe Investment Capital Preservation Plans - Newser
Bio Techne Corporation Stock Flags Risk Zone in Volatility Index2025 Pullback Review & Momentum Based Trading Signals - 더경남뉴스
Bio-Techne Stock: Analyst Estimates & Ratings - Barchart.com
How Bio Techne Corporation stock performs during market volatilityTrade Entry Report & Community Trade Idea Sharing - beatles.ru
What makes Bio Techne Corporation stock price move sharplyJuly 2025 Earnings & Expert Approved Momentum Ideas - 더경남뉴스
Stock Analysis | Bio-Techne OutlookA Stock to Watch with Mixed Signals - AInvest
Bio-Techne: Key Dividend Information and Recent Developments Ahead of Ex-Dividend Date on Aug 18, 2025 - AInvest
Three Companies Trading Ex-Dividend on 8/18/25 - AInvest
Ex-Dividend Reminder: Bio-Techne, First Hawaiian and CNA Financial - Nasdaq
Recombinant Human Hair Keratin Protein Market 2025 Trends and Updates - GlobeNewswire Inc.
Bio-Techne's (NASDAQ:TECH) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know - Yahoo Finance
Bio-Techne Corporation shares rise 2.40% intraday as S&P 500, Nasdaq futures hit record highs. - AInvest
Bio-Techne's Q4 2025: Navigating Contradictions in NIH Funding, China Growth, and Revenue Outlook - AInvest
The 5 Most Interesting Analyst Questions From Bio-Techne’s Q2 Earnings Call - Yahoo Finance
Stock Market Rally: Revvity, Avantor, Azenta, Bio-Techne, Amneal Shares Surge Amid Fed Interest Rate Cut Hopes - AInvest
Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know - Yahoo Finance
TECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty - Yahoo Finance
Bio-Techne Earnings: Fourth-Quarter Results In-Line, but Volatile US Policy Is Hurting End Markets - Morningstar
Bio-Techne Leads Key Proteomic Reagent Markets, but Near-Term Challenges Loom - Morningstar
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls - MSN
Can Bio Techne Corporation disrupt its industryMaximum Leverage Stock Strategy - thegnnews.com
Bio-Techne Corp Q4 Earnings: Revenue Exceeds Estimates at $317M, Adjusted EPS Rises to $0.53, GAAP EPS Misses - AInvest
A Quick Look at Today's Ratings for Bio-Techne(TECH.US), With a Forecast Between $53 to $75 - 富途牛牛
Stocks making big moves yesterday: Bloomin' Brands, Bio-Techne, Snap, Grocery Outlet, and Paramount - Yahoo Finance
A Quick Look at Today's Ratings for Bio-Techne(TECH.US), With a Forecast Between $59 to $65 - 富途牛牛
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):